5 min read Healthcare RayzeBio, Neumora Perk Up the IPO Market, Elevating $561M for Scientific Trials September 16, 2023 Read More
4 min read Healthcare Acelyrin Plans IPO to Fund Pivotal Assessments of Drug That Might Rival AbbVie’s Humira April 15, 2023 Read More
